UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
(State or other jurisdiction | (Commission | (IRS Employer |
of incorporation) | File Number) | Identification No.) |
(Address of principal executive offices) (Zip Code)
(
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Trading |
| Name of each exchange | |
Title of each class | Symbol(s) | on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01. Entry into a Material Definitive Agreement.
Pursuant to the Credit Agreement, dated July 26, 2023 (the “Credit Agreement”), by and among Harmony Biosciences Holdings, Inc. (the “Company”), the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent (the “Administrative Agent”), the Company maintains an existing senior secured term loan (the “Existing Term Loan”) (i) with an outstanding aggregate principal amount as of September 21, 2023 of $185 million, (ii) that bears interest at a per annum rate equal to, at the Company’s option, (x) a base rate plus a specified margin ranging from 2.50% to 3.00%, based on the Company’s senior secured net leverage ratio or (y) Term SOFR plus a credit spread adjustment of 0.10% plus a specified margin ranging from 3.50% to 4.00%, based on the Company’s senior secured net leverage ratio and (iii) that matures on July 26, 2028.
On September 21, 2023 (the “Closing Date”), the Company, as borrower, entered into the First Incremental Amendment (the “First Incremental Amendment”) with the Administrative Agent and Bank of America, N.A., as incremental lender. The First Incremental Amendment provides for an incremental senior secured term loan (the “Incremental Term Loan”) in an aggregate principal amount of $15 million that was advanced on the Closing Date. The proceeds of the Incremental Term Loan were used to pay transaction fees and expenses in connection with the First Incremental Amendment and otherwise will be used for general corporate purposes.
The First Incremental Amendment amends the Credit Agreement and provides that the Incremental Term Loan will have identical terms as the Existing Term Loan. In addition, on the Closing Date the Company paid an upfront fee of 0.50% of the aggregate principal amount of the Incremental Term Loan.
Except as amended by the First Incremental Amendment, the remaining terms of the Credit Agreement remain in full force and effect.
The foregoing descriptions of the First Incremental Amendment do not purport to be complete and are qualified in their entirety by reference to the full text of the First Incremental Amendment, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit |
| |
No. | Description | |
10.1* | ||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
HARMONY BIOSCIENCES HOLDINGS, INC. | ||
Date: September 25, 2023 | By: | /s/ Sandip Kapadia |
Sandip Kapadia | ||
Chief Financial Officer |
Exhibit 10.1
Execution Version
FIRST INCREMENTAL AMENDMENT
This FIRST INCREMENTAL AMENDMENT (this “First Incremental Amendment”), dated as of September 21, 2023, is entered into among HARMONY BIOSCIENCES HOLDINGS, INC., a Delaware corporation (the “Borrower”), each of the Subsidiary Guarantors party hereto, the Incremental Lenders (as defined below) and JPMOrgan CHASE BANK, N.A., as administrative agent (in such capacity, the “Administrative Agent”).
RECITALS
WHEREAS, the Borrower, the lenders from time to time party thereto, and JPMorgan Chase Bank, N.A., as Administrative Agent, are party to the Credit Agreement, dated as of July 26, 2023 (as may be amended, restated, amended and restated, modified, extended, replaced, or supplemented from time to time prior to the date hereof, the “Credit Agreement”; the Credit Agreement as amended by this First Incremental Amendment, the “Amended Credit Agreement”); and
WHEREAS, pursuant to Section 2.20 of the Credit Agreement, the Borrower may increase the principal amount of the Term Loans of any existing Class by requesting new commitments to provide term loans by, among other things, entering into an Incremental Amendment with the Administrative Agent and each Incremental Lender providing such Incremental Term Loans;
WHEREAS, the Borrower has notified the Administrative Agent and the First Incremental Amendment Lead Arranger (as defined below) of its desire to, substantially concurrently with the effectiveness of this First Incremental Amendment, borrow Incremental Term Loans (the “2023 Incremental Term Loans”) in an aggregate principal amount of $15,000,000 on the First Incremental Amendment Effective Date (as defined below);
WHEREAS, after giving effect to this First Incremental Amendment, the outstanding aggregate principal amount of Term Loans as of the First Incremental Amendment Effective Date will be $200,000,000;
WHEREAS, the 2023 Incremental Term Loans are being incurred in reliance on clause (c) of the definition of “Incremental Cap”;
WHEREAS, each Lender signatory hereto as an “Incremental Lender” (each such Lender, an “Incremental Lender”) has agreed to provide 2023 Incremental Term Loans to the Borrower in an aggregate principal amount set forth opposite its name under the column entitled “2023 Incremental Term Loans” in Schedule 1 attached hereto in accordance with the terms of this First Incremental Amendment and the Amended Credit Agreement and subject to the conditions set forth in this First Incremental Amendment;
NOW, THEREFORE, in consideration of the premises and the mutual covenants contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:
2
“First Incremental Amendment” shall mean that certain First Incremental Amendment to this Agreement, dated as of September 21, 2023, by and among the Borrower, each of the Subsidiary Guarantors party thereto, the Administrative Agent and the Incremental Lenders party thereto.
“First Incremental Amendment Effective Date” has the meaning assigned to such term in the First Incremental Amendment.
Repayment and Amortization of Loans. The Borrower hereby unconditionally promises to repay the Term Loans on the last day of each calendar quarter (commencing December 31, 2023) in a principal amount equal to (i) for each calendar quarter from (and including) December 31, 2023 through (and including) September 30, 2025, 1.875% of the outstanding amount of the Term Loans on the First Incremental Amendment Effective Date (after giving effect to the making of the Incremental Term Loans on such date) (as such installment amount may be adjusted from time to time pursuant to Section 2.11(a) and Section 2.11(f)) and (ii) for each calendar quarter from (and including) December 31, 2025 and thereafter until the Maturity Date, 2.50% of the outstanding amount of the Term Loans on the First Incremental Amendment Effective Date (after giving effect to the making of the Incremental Term Loans on such date) (as such installment amount may be adjusted from time to time pursuant to Section 2.11(a) and Section 2.11(f)). To the extent not previously repaid, all unpaid Loans shall be paid in full in Dollars by the Borrower on the Maturity Date.
3
4
5
[remainder of page intentionally left blank]
6
Each of the parties hereto has caused a counterpart of this First Incremental Amendment to be duly executed and delivered as of the date first above written.
HARMONY BIOSCIENCES HOLDINGS, INC., as the Borrower | ||
By: | /s/ Jeffrey M. Dayno | |
Name: | Jeffrey M. Dayno | |
Title: | President and Chief Executive Officer |
HARMONY BIOSCIENCES, LLC, as a Subsidiary Guarantor | ||
By: | /s/ Jeffrey M. Dayno | |
Name: | Jeffrey M. Dayno | |
Title: | President and Chief Executive Officer |
7
JPMORGAN CHASE BANK, N.A.,
as Administrative Agent
By: /s/ Melanie Her
Name: Melanie Her
Title: Vice President
8
Bank of America, N.A., as an Incremental Lender
By: /s/ Irina Froment
Name: Irina Froment
Title: Senior Vice President
9